ProQR Therapeutics NV (PRQR)
2.00
+0.06
(+3.09%)
USD |
NASDAQ |
May 01, 16:00
2.00
0.00 (0.00%)
After-Hours: 20:00
ProQR Therapeutics EPS Diluted (Quarterly): -0.0754 for Dec. 31, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.0754 |
| September 30, 2023 | -0.0762 |
| June 30, 2023 | -0.109 |
| March 31, 2023 | -0.1181 |
| December 31, 2022 | -0.1841 |
| September 30, 2022 | -0.3324 |
| June 30, 2022 | -0.2024 |
| March 31, 2022 | -0.2244 |
| December 31, 2021 | -0.2974 |
| September 30, 2021 | -0.2594 |
| June 30, 2021 | -0.2892 |
| March 31, 2021 | -0.3013 |
| December 31, 2020 | -0.31 |
| September 30, 2020 | -0.304 |
| June 30, 2020 | -0.0881 |
| March 31, 2020 | -0.3531 |
| December 31, 2019 | -0.4319 |
| September 30, 2019 | -0.3447 |
| June 30, 2019 | -0.337 |
| March 31, 2019 | -0.4089 |
| December 31, 2018 | -0.3765 |
| Date | Value |
|---|---|
| September 30, 2018 | -0.2093 |
| June 30, 2018 | -0.2746 |
| March 31, 2018 | -0.4054 |
| December 31, 2017 | -0.4593 |
| September 30, 2017 | -0.4938 |
| June 30, 2017 | -0.5171 |
| March 31, 2017 | -0.4794 |
| December 31, 2016 | -0.4099 |
| September 30, 2016 | -0.4799 |
| June 30, 2016 | -0.4858 |
| March 31, 2016 | -0.4854 |
| December 31, 2015 | -0.2845 |
| September 30, 2015 | -0.3001 |
| June 30, 2015 | -0.4089 |
| March 31, 2015 | 0.0113 |
| December 31, 2014 | -0.1124 |
| September 30, 2014 | -0.5699 |
| June 30, 2014 | -0.3138 |
| March 31, 2014 | -0.1184 |
| December 31, 2013 | -0.1001 |
| September 30, 2013 | -0.0523 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.4319
Minimum
Dec 2019
-0.0754
Maximum
Dec 2023
-0.2441
Average
-0.2892
Median
Jun 2021
EPS Diluted (Quarterly) Benchmarks
| uniQure NV | -1.53 |
| Merus NV | -1.09 |
| argenx SE | -1.69 |
| Pharming Group | -0.05 |
| Pharvaris NV | -0.8185 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.905M |
| Revenue (Quarterly) | 3.537M |
| Total Expenses (Quarterly) | 13.44M |
| Enterprise Value | 31.11M |
| Profit Margin (Quarterly) | -167.0% |
| Earnings Yield | -18.94% |
| Normalized Earnings Yield | -21.56 |